Clinical Trial

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Name: IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features — clinical trial record (NCT07376603)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach

Trial Details

NCT Number	NCT07376603
Lead Sponsor	Qiaojuan Guo
Conditions	Nasopharyngeal Cancinoma (NPC), Intensity-modulated Radiotherapy, Stage IB
Enrollment	169 participants
Start Date	2026-01-12
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-29